FR901228
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for FR901228, covering 2013-01-16 to 2024-03-04. Get the full timeline:
Most recent: Clinical Trial Update: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [Phase 2]